Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Pfizer recalls 28 lots of contraceptive pill in US

This article was originally published in Scrip

Executive Summary

Pfizer has voluntarily recalled 14 lots of Lo/Ovral-28 (norgestrel and ethinyl estradiol) Tablets and 14 lots of the generic version of the same drug in the US, following an investigation which revealed that some blister packs may contain an inexact count of inert or active ingredients and that tablets may be out of sequence. The blister packs are supposed to contain 21 tablets of active ingredient and seven inert ones, and errors in the daily dosing leave women without adequate contraception and at risk of unplanned pregnancy. Patients using the affected products are recommended to notify their physician, return the product to the pharmacy and report any adverse events or side effects.




Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts